As previously stated, menopause is a turning point in a women’s life, a rite of passage that will commence the next step. Indeed, menopause itself has multiple symptoms that can be treated with herbs. Furthermore, using herbs from Traditional Chinese Medicine (TCM) is considered an alternative treatment for osteoporosis since most current treatments rely on hormone therapy, bisphosphonates, selective estrogen receptor modulators, etc. Nevertheless, these treatments can have secondary effects leading to increased risk of cardiovascular disease, breast, and endometrial cancer, gastrointestinal intolerances, to mention some. On the other hand, using herbs from TCM exerts therapeutic effects through a multi-component, multi-pathways, and multi-targeted way, according to postmenopausal osteoporosis physiopathology.

What is postmenopausal osteoporosis?

The etiology of postmenopausal osteoporosis is a systemic metabolic skeletal disease triggered by low estrogen concentration. Indeed, the rapid changes in hormonal levels in postmenopausal women increase the rate of bone remodeling.

 Furthermore, this condition characterizes by the high fragility of the bone tissue resulting in structural deterioration and increased risk of fracture, lower quality of life, increased morbidity and mortality rates. 

Osteoporosis affects 200 million postmenopausal women worldwide. As a chronic condition, postmenopausal osteoporosis needs long-term treatment with medication associated with adverse secondary effects. 

Therapeutic agents used for osteoporosis:
  • Hormone replacement therapy has adverse long-term safety concerns. The long-term use of this therapy is associated with cardiovascular disease, endometrial and breast cancer, stroke, and venous thromboembolism.
  • The use of bisphosphonates therapy links to gastrointestinal intolerance, jaw osteonecrosis, atrial fibrillation, and atypical femoral fractures.
  • Salmon calcitonin associates with a higher risk of cancer.
  • Parathyroid analogs are known to have secondary effects such as nausea, dizziness, and hypercalcemia.

Traditional Chinese Medicine and postmenopausal osteoporosis.

Herba Epimedium.

This herb has been used for centuries in TCM to treat a broad range of conditions like fatigue, sexual dysfunction, rheumatic diseases, and osteoporosis. Herba Epimedium, also known as YinYangHuo in Chinese, has around 260 bioactive compounds like icariin, icaritin, anhydroicaritin, and epimedin.

In vivo studies:

In vivo studies have shown that the Herba Epimedium extract prevented bone loss in ovariectomized (OVX) rats and improved biomechanical functions. Regarding turnover biomarkers, the group treated with Herba Epimedium showed lower urinary deoxypyridinoline levels, a marker of bone resorption.

Flavonoids derived from Herba Epimedium have a crucial role in modulating bone-formation pathways. Indeed, this same study showed an upregulation of procollagen type I N-terminal propeptide (PINP) and increased serum osteocalcin and type I collagen in OVX rats.

Icariin, a principal active constituent of Herba Epimedium, is associated with decreased tartrate-resistant acid phosphatase (TRAP) and bone alkaline phosphatase (BALP), as well as serum osteocalcin, C-terminal telopeptide of type I collagen (CTX) levels, and ALP activity. This coincides with reduced bone resorption. 

As far as genetic expression, the bioactive compounds found in Herba epimedium could be linked to better cognitive outcomes, resulting in reduced mobility loss. Components like icariin and TFE are linked to improved serum estrogen levels and an increase in estrogen receptor α (ERα) and ERβ mRNA expression of the hypothalamus and hippocampus. Consequently, this can reverse or slow the osteoporosis progression as well as improve neuroendocrine regulation.

In vitro results:

The findings associated with Herba Epimedium are outstanding, as its bioactive compounds can modulate cellular differentiation. Indeed, studies show that Herba Epimedium bioactive compounds can stimulate osteoblasts’ proliferation, differentiation, and mineralization. Furthermore, this mechanism also benefits the formation of osteoblasts instead of adipocytes, improving structural function and reducing fat mass. In addition, studies show that this herbal treatment inhibits the proliferation and differentiation of osteoclasts, promotes osteoclast apoptosis, therefore decreasing bone resorption.

Nowadays, we can look for a better way to treat this multi-pathway and multi-factorial condition with herbal components that promote better structure and modulate this condition from the root cause. The neverending list of adverse effects due to the excessive medication has left us no other option than to turn in another direction. Promoting the use of herbal therapy is a safer long-term alternative.- Ana Paola Rodríguez Arciniega, MS.


Lin, Jing et al. “Chinese single herbs and active ingredients for postmenopausal osteoporosis: From preclinical evidence to action mechanism.” Bioscience trends vol. 11,5 (2017): 496-506. doi:10.5582/bst.2017.01216

Additional Online Links & Resources (Available 24/7)


Online Appointments or Consultations:


Online Physical Injury / Accident Intake Form: 


Online Functional Medicine Assessment:


Professional Scope of Practice *

The information herein on "Postmenopausal Osteoporosis and Aging Vs. Traditional Chinese Medicine" is not intended to replace a one-on-one relationship with a qualified health care professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional.

Blog Information & Scope Discussions

Our information scope is limited to Chiropractic, musculoskeletal, physical medicines, wellness, contributing etiological viscerosomatic disturbances within clinical presentations, associated somatovisceral reflex clinical dynamics, subluxation complexes, sensitive health issues, and/or functional medicine articles, topics, and discussions.

We provide and present clinical collaboration with specialists from various disciplines. Each specialist is governed by their professional scope of practice and their jurisdiction of licensure. We use functional health & wellness protocols to treat and support care for the injuries or disorders of the musculoskeletal system.

Our videos, posts, topics, subjects, and insights cover clinical matters, issues, and topics that relate to and directly or indirectly support our clinical scope of practice.*

Our office has reasonably attempted to provide supportive citations and has identified the relevant research study or studies supporting our posts. We provide copies of supporting research studies available to regulatory boards and the public upon request.

We understand that we cover matters that require an additional explanation of how it may assist in a particular care plan or treatment protocol; therefore, to further discuss the subject matter above, please feel free to ask Dr. Alex Jimenez, DC, or contact us at 915-850-0900.

We are here to help you and your family.


Dr. Alex Jimenez DC, MSACP, RN*, CCST, IFMCP*, CIFM*, ATN*


Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License # TX5807, New Mexico DC License # NM-DC2182

Licensed as a Registered Nurse (RN*) in Florida
Florida License RN License # RN9617241 (Control No. 3558029)
Compact Status: Multi-State License: Authorized to Practice in 40 States*

Presently Matriculated: ICHS: MSN* FNP (Family Nurse Practitioner Program)

Dr. Alex Jimenez DC, MSACP, RN* CIFM*, IFMCP*, ATN*, CCST
My Digital Business Card

What's your reaction?